Is SPIEF or JNJ a better dividend investment in 2026?

SPIEF currently yields 2000000.00% with a 5% 5-year dividend growth rate. JNJ yields 2.13% with 5.8% growth. The better choice depends on your goal: SPIEF offers higher current income.

What is the dividend yield difference between SPIEF and JNJ?

SPIEF has a forward dividend yield of 2000000.00% ($2.00/share annually). JNJ yields 2.13% ($5.20/share annually). The yield gap is 1999997.87 percentage points.

Home › Compare › SPIEF vs JNJ

SPIEF vs JNJ: Dividend Comparison 2026

SPIEF yields 2000000.00% · JNJ yields 2.13%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 SPIEF wins by $4.879226400974806e+39M in total portfolio value

INVESTMENT

TIME HORIZON10 years

SPIEF

● Live price

2000000.00%

Share price

$0.00

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$4.879226400974806e+39M

Annual income

$4,878,746,539,330,970,000,000,000,000,000,000,000,000,000,000.00

Full SPIEF calculator →

JNJ

Johnson & Johnson

● Live price

2.13%

Share price

$244.44

Annual div

$5.20

5Y div CAGR

28%

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$30.3K

Annual income

$4,689.40

Full JNJ calculator →

Portfolio growth — SPIEF vs JNJ

📍 SPIEF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	SPIEF	JNJ
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, SPIEF + JNJ cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

SPIEF pays

JNJ pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

SPIEF

Annual income on $10K today (after 15% tax)

$170,000,000.00/yr

After 10yr DRIP, annual income (after tax)

$4,146,934,558,431,324,500,000,000,000,000,000,000,000,000,000.00/yr

JNJ

Annual income on $10K today (after 15% tax)

$180.82/yr

After 10yr DRIP, annual income (after tax)

$3,985.99/yr

At 15% tax rate, SPIEF beats the other by $4,146,934,558,431,324,500,000,000,000,000,000,000,000,000,000.00/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of SPIEF + JNJ for your $10,000?

SPIEF: 50%JNJ: 50%

100% JNJ50/50100% SPIEF

Portfolio after 10yr

$2.439613200487403e+39M

Annual income

$2,439,373,269,665,485,000,000,000,000,000,000,000,000,000,000.00/yr

Blended yield

99.99%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

SPIEF

Analyst Ratings

Buy

Consensus: Buy

Price Target

$7.00

+6999900.0% upside vs current

Range: $7.00 — $7.00

Altman Z

-3.9

Piotroski

4/9

JNJ

Analyst Ratings

Buy

Hold

Sell

Consensus: Buy

Price Target

$228.73

-6.4% upside vs current

Range: $190.00 — $265.00

Altman Z

5.2

Piotroski

4/9

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

SPIEF buys

JNJ buys

No recent congressional trades found for SPIEF or JNJ in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricSPIEFJNJ

Forward yield	2000000.00% ✓	2.13%
Annual dividend / share	$2.00	$5.20 ✓
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	0%	28% ✓
Portfolio after 10y	$4.879226400974806e+39M	$30.3K ✓
Annual income after 10y	$4,878,746,539,330,970,000,000,000,000,000,000,000,000,000,000.00 ✓	$4,689.40
Total dividends collected	$4.879195005460081e+39M	$15.4K ✓
Payment frequency	quarterly	quarterly
Sector	Stock	Healthcare
Analyst consensus	Buy	Buy
Analyst price target	$7.00	$228.73 ✓

Year-by-year: SPIEF vs JNJ ($10,000, DRIP)

Year	SPIEF Portfolio	SPIEF Income/yr	JNJ Portfolio	JNJ Income/yr	Gap
1← crossover	$200,010,700	$200,000,000.00	$10,592	$272.30	+$200.00M → SPIEF
2	$3,738,731,768,458	$3,738,517,757,009.35	$11,289	$357.73	+$3738731.76M → SPIEF
3	$65,315,062,866,930,490	$65,311,062,423,938,240.00	$12,123	$472.89	+$65315062866.92M → SPIEF
4	$1,066,400,830,062,625,000,000	$1,066,330,942,945,357,500,000.00	$13,141	$629.86	+$1066400830062625.00M → SPIEF
5	$16,272,182,796,453,826,000,000,000	$16,271,041,747,565,660,000,000,000.00	$14,408	$846.81	+$16272182796453826560.00M → SPIEF
6	$232,054,240,113,661,900,000,000,000,000	$232,036,828,878,069,680,000,000,000,000.00	$16,021	$1,151.60	+$2.3205424011366188e+23M → SPIEF
7	$3,092,799,066,104,688,500,000,000,000,000,000	$3,092,550,768,067,767,400,000,000,000,000,000.00	$18,122	$1,588.22	+$3.0927990661046884e+27M → SPIEF
8	$38,524,105,697,352,694,000,000,000,000,000,000,000	$38,520,796,402,351,967,000,000,000,000,000,000,000.00	$20,930	$2,228.20	+$3.8524105697352695e+31M → SPIEF
9	$448,468,826,014,798,700,000,000,000,000,000,000,000,000	$448,427,605,221,702,600,000,000,000,000,000,000,000,000.00	$24,792	$3,191.91	+$4.484688260147987e+35M → SPIEF
10	$4,879,226,400,974,806,000,000,000,000,000,000,000,000,000,000	$4,878,746,539,330,970,000,000,000,000,000,000,000,000,000,000.00	$30,274	$4,689.40	+$4.879226400974806e+39M → SPIEF

SPIEF vs JNJ: Complete Analysis 2026

SPIEF — Stock

SPI Energy Co., Ltd. operates as a renewable energy company in North America, Australia, Asia, and Europe. The company offers solar storage and module; renewable energy system solutions to residential and small commercial markets; and EPC services to third party project developers, as well as develops, owns, and operates solar projects that sell electricity to the grid. It also provides commercial electric vehicles, EV charger solutions, electric pickup trucks and scooters, and other EV products. The company was formerly known as Solar Power, Inc. and changed its name to SPI Energy Co., Ltd. in January 2016. SPI Energy Co., Ltd. was founded in 2006 and is headquartered in Sacramento, California.

Full SPIEF Calculator →

JNJ — Healthcare

Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.

Full JNJ Calculator →

📬

Get this SPIEF vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

SPIEF vs SCHD SPIEF vs JEPI SPIEF vs O SPIEF vs KO SPIEF vs MAIN SPIEF vs ABBV SPIEF vs MRK SPIEF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.